| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |